Proline rich antimicrobial peptide, PR-39 gene transduction altered invasive activity and actin structure in human hepatocellular carcinoma cells

British Journal of Cancer

Volumn 81, Issue 3, 1999, Pages 393-403

  Ohtake, T ^a   Fujimoto, Y ^a   Ikuta, K ^a   Saito, H ^a   Ohhira, M ^a   Ono, M ^a   Kohgo, Y ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Actin; Antimicrobial peptide; Hepatocellular carcinoma; PR 39; Syndecan

Indexed keywords

ACTIN; COLLAGEN TYPE 1; PEPTIDE; PROLINE; SYNDECAN;

ACTIN FILAMENT; ANTIMICROBIAL ACTIVITY; ARTICLE; CANCER INVASION; CELL LINE; CELL MOTILITY; CELL STRUCTURE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMAGING SYSTEM; LIVER CELL CARCINOMA; PRIORITY JOURNAL;

ACTINS; ANTIMICROBIAL CATIONIC PEPTIDES; CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; CHLORATES; COLLAGEN; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOSAMINOGLYCANS; HUMANS; LIVER NEOPLASMS; MEMBRANE GLYCOPROTEINS; MICROFILAMENTS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PEPTIDES; PROTEOGLYCANS; RECOMBINANT FUSION PROTEINS; SULFUR; SYNDECAN-1; SYNDECANS; TRANSFECTION;

EID: 0032875198     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690707     Document Type: Article

References (38)

1. Agerberth B, Lee J-Y, Bergman T, Carlquist M, Boman HG, Mutt V and Jornvall H (1991) Amino acid sequence of PR-39: isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. Eur J Biochem 202: 849-854
2. Agerberth B, Gunne H, Odeberg J, Kogner P, Boman HG and Gudmundsson GB (1995) FALL-39. putative human peptide antibiotics, is cysteine free and expressed in bone marrow and testis. Proc Natl Acad Sci USA 92: 195-199
3. Agerberth B, Gunne H, Odeberg J, Kogner P, Boman HG and Gudmundsson GH (1996) PR-39, a proline-rich peptide antibiotic from pig. and FALL-39, a tentative human counterpart. Vet Immunol Immunopathol 54: 127-131
4. Albini A, Iwamoto Y, Kleinmann HK, Martin GR, Aaronson SA, Kozolowski JM and Ecewan RN (1987) A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239-3245
5. Albrecht-Buchler G (1977) The phagokinetic tracks of 3T3 cells. Cell 11: 359-404
6. Aycock RS and Seyer JM (1989) Collagens of normal and cirrhotic human liver. Connect Tissue Res 23: 19-31
7. Bernfield M, Hinkes, MT and Gallo RL (1993) Developmental expression of the syndecans: possible function and regulation. Development Suppl: 205-212
8. Boman HG, Agerberth B and Boman A (1993) Mechanism of action on Escherichia coli of Cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect Immun 61: 2978-2984
9. Boman HG (1995) Peptide antibiotics and their role in innate immunity. Annu Rev Immunol 13: 61-92
10. C10. J Biol Chem 273: 28978-28985
11. Dickson RB, Johnson MD, Maemura M and Low J (1996) Anti-invasion drugs. Breast Cancer Res Treat 38: 121-132
12. Doi I, Namba M and Sato L (1975) Establishment and some biological characteristics of human hepatoma cell lines. Jpn J Cancer Res 66: 385-392
13. Effert PJ, Gastl G and Strohmeyer T (1996) Current and future strategies to block tumor angiogenesis, invasion, and metastasis. World J Urol 14: 131-140
14. Elenius K, Salmivirta M, Inki P, Mali M and Jalkanen M (1990) Binding of human syndecan to extracellular matrix proteins. J Biol Chem 265: 17837-17843
15. Elenius K, Määttä A. Saimivirta M and Jalkanen M (1992) Growth factors induce 3T3 cells to express bFGF-binding syndecan. J Biol Chem 267: 6435-6441
16. Gallo RL, Ono M, Povsic T, Page C, Eriksson E, Klagsbrunl M and Bernfield M (1994) Syndecan, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proc Natl Acad Sci USA 91: 11035-11039
17. Gout I, Dhand R, Hiles ID, Fry MJ, Panayotou G, Das P, Truong O, Totty NF, Hsuan J, Booker GW, Campbell ID and Waterfield MD (1993) The GTPase dynamin binds to and is activated by a subset of SH3 domains. Cell 75: 25-36
18. Hinkes MT, Goldberger OA, Neumann PE, Kokenyesi R and Bernfield M (1993) Organization and promoter activity of the mouse syndecan-1 gene. J Biol Chem 268; 11440-11448
19. Huh N and Utakoji T (1981) Production of HBs-antigen by two new human hepatoma cell lines and its enhancement by dexamethasone. Jpn J Cancer Res 72: 178-179
20. Koda JE, Rapraeger A and Bernfield M (1985) Heparan sulfate proteoglycans from mouse mammary epithelial cells. Cell surface proteoglycans as a receptor for interstitial collagens. J Biol Chem 260: 8157-8162
21. Liebersbach BF and Sanderson RD (1994) Expression of syndecan-1 inhibit cell invasion into type I collagen. J Biol Chem 269: 20013-20019
22. Martin E, Ganz T and Lehrer RI (1995) Defensins and other endogenous peptide antibiotics of vertebrates. J Leukocyte Biol 58: 128-136
23. Matsumoto A, Ono M, Fujimoto Y, Gallo RL, Bernfield M and Kohgo Y (1997) Reduced expression of syndecan-1 in human hepatocellular carcinoma with high metastatic potential. Int J Cancer 74: 482-491
24. Musacchio A, Wilmanns M and Saraste M (1994) Structure and function of the SH3 domain. Prog Biophys Molec Biol 61: 283-297
25. Pawson T (1995) Protein modules and signaling networks. Nature 373: 573-580
26. Rapraeger A, Jalkanen M, Endo E, Koda JE and Bernfield M (1985) The cell-surface proteoglycan from mouse mammary epithelial cells bears chondroitin-sulfate and heparan-sulfate GAGs. J Biol Chem 260: 11046-11052
27. Sanderson RD and Bernfield M (1988) Molecular polymorphism of a cell surface proteoglycan: distinct structures on simple and stratified epithelia. Proc Natl Acad Sci USA 85: 9562-9566
28. Sanderson RD, Hinkes MT and Bernfield M (1992) Syndecan-1, a cell-surface proteoglycan, changes in size and abundance when keratinocytes stratify. J Invest Dermatol 99: 390-396
29. Saunders S and Bernfield M (1988) Cell surface proteoglycan binds mouse mammary epithelial cells to fibronectin and behaves as a receptor on interstitial matrix. J Cell Biol 106: 423-430
30. Saunders S, Jalkanen M, O'Farrell S and Bernfield M (1989) Molecular cloning of syndecan, an integral membrane proteoglycan. J Cell Biol 108: 1547-1556
31. phox. Proc Natl Acad Sci USA 93: 6014-6018
32. Solursh M, Reiter RS, Jensen KL, Kato M and Bernfield M (1990) Transient expression of a cell surface heparan sulfate proteoglycan (syndecan) during limb development Dev Biol 140; 83-92
33. Storici P and Zanetti M (1993) A cDNA derived from pig bone marrow cells predicts a sequence identical to the intestinal antibacterial peptide PR-39, Biochem Biophys Res Commun 196: 1058-1065
34. Stossel T (1993) On the crawling of animal cells. Science 260: 1086-1094
35. Vanio S, Lehtonen E, Jalkanen M, Bernfield M and Saxen L (1989) Epithelial-mesenchymal interactions regulate the stage-specific expression of a cell surface proteoglycan, syndecan, in the developing kidney. Dev Biol 134: 382-391
36. Vainio S, Thesleff I (1992) Coordinated induction of cell proliferation and syndecan expression in dental mesenchyme by epithelium: evidence for diffusible signals. Dev Dyn 194: 105-117
37. Yeaman C and Rapraeger A (1993) Post-transcriptional regulation of syndecan-1 expression by cAMP in peritoneal macrophages. J Cell Biol 122: 941-950
38. Yu H, Chen JK, Feng S, Dalgarno DC, Brauer AW and Schreiber SL (1994) Structural basis for the binding of proline-rich peptides to SH3 domains. Cell 76: 933-945